20 results
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
PATIENT AGE >2 Years - Pediatric Blunt Head Trauma (PECARN Study) #Diagnosis #Management #Peds #EM #Algorithm
PATIENT AGE >2 Years ... Diagnosis #Management #Peds ... #EM #Algorithm
PATIENT AGE <2 Years - Pediatric Blunt Head Trauma (PECARN Study) #Diagnosis #Management #Peds #EM #Algorithm
PATIENT AGE <2 Years ... Diagnosis #Management #Peds ... #EM #Algorithm
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
NEJMoa1101549 #EBM ... #Peds #Pediatrics ... Boluses #Africa #NEJM
A 48-year-old-man presented to the dermatology clinic with a whitish discoloration and hyperkeratosis of the first
A 48-year-old-man ... #Clinical #IM #InfectiousDisease ... RapidProgression #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Pyogenic Granuloma of the Conjunctiva - A 30-year-old man presented with a pedunculated lesion on his
Conjunctiva - A 30-year-old ... Clinical #Ophth #EM ... #Conjunctival #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia #EBM #Peds #Budesonide #BronchopulmonaryDysplasia #BPD #VisualAbstract #NEJM
Bronchopulmonary Dysplasia #EBM ... #Peds #Budesonide ... VisualAbstract #NEJM